Transurethral Resection
Also known as: Transurethral resection (TUR)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB10804 | Bacillus calmette-guerin substrain connaught live antigen | Indicated for intravesical use in the treatment and prophylaxis of carcinoma in situ (CIS) of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1... |
| DB16648 | Bacillus calmette-guerin substrain russian BCG-I live antigen | An intravesically-administered live BCG vaccine used to treat papillary urothelial cell carcinoma of the bladder. |
| DB00445 | Epirubicin | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00445 | Epirubicin | DNA topoisomerase 2-alpha | target |
| DB00445 | Epirubicin | DNA | target |
| DB00445 | Epirubicin | Multidrug resistance-associated protein 1 | transporter |
| DB00445 | Epirubicin | UDP-glucuronosyltransferase 2B7 | enzyme |
| DB00445 | Epirubicin | Cytosolic phospholipase A2 | enzyme |